chrisvoncsefalvay/vaers-outcomes huggingface dataset:
looked bleak; ran out of energy; Light headedness; Weak in both hands; dizzy; looked paled; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (ran out of energy), DIZZINESS (Light headedness), MUSCULAR WEAKNESS (Weak in both hands), DIZZINESS (dizzy) and PALLOR (looked paled) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced ASTHENIA (ran out of energy), DIZZINESS (Light headedness), MUSCULAR WEAKNESS (Weak in both hands), DIZZINESS (dizzy) and PALLOR (looked paled). On 03-Feb-2021, the patient experienced DEPRESSION (looked bleak). At the time of the report, ASTHENIA (ran out of energy), DIZZINESS (Light headedness), MUSCULAR WEAKNESS (Weak in both hands), DIZZINESS (dizzy), PALLOR (looked paled) and DEPRESSION (looked bleak) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2021, Heart rate: increased (High) increased. On an unknown date, Electrocardiogram: unknown (Inconclusive) Unknown. On an unknown date, Glucose tolerance test: unknown (Inconclusive) Unknown. On an unknown date, Pulmonary function test: unknown (Inconclusive) Unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   This case was linked to MOD-2021-035131 (Patient Link).
Patient reported lightheadness, dizziness, slight SOB, slight dysphagia and slight chest tightness, with exp/inspir wheezing noted in bilateral lungs upon auscultation.  Initial onsight treatment consisted of 10L O2 via non-rebreather and 2 puffs from proventil inhaler to stablize patient before EMS responded.  ED treatment consisted of (1) albuteral inhaler treatment, and (1) capsule 25mg of diphenhydramine PO.
Pharmacist states they gave full doses for boosters instead of half doses.; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 25-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.). At the time of the report, ACCIDENTAL OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment informations were reported.
On November 08, I had a little congestion. I completed a COVID-19 home test the next day. I called my doctor to request PAXLOVID. By this time, I had developed a little cough. I took one dose. I went to lie down, and my heart started racing between 160 to 180 which lasted for around 4 hours on and off. I was so tired that I kept wanting to lay down. They did 2 EKG and diagnosed me with Supraventricular Tachycardia. My blood oxygen was 98% when I was in the ER. I had no temperature. I would take over the counter SUDAFED and NYQUIL as the symptoms were milder than a normal cold. I have since completely recovered from my symptoms. I started having heart issues on October 2022.
Slight headache; achiness to the injection arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A 73-year-old female patient received BNT162b2 (BNT162B2), on 25Mar2021 as dose 2, single, injection given in arm (Lot number: ER2613) at the age of 71 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (ongoing), notes: Start date asked but unknown. High blood pressure Diagnosed for 20 years; "High cholesterol" (ongoing); "Arthritis" (unspecified if ongoing), notes: Start date asked but unknown. Arthritis diagnosed for last 5 years. It's been bothering her. Concomitant medication(s) included: LISINOPRIL taken for hypertension; SIMVASTATIN taken for blood cholesterol increased. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, LOT: EM9810, EXP: Unknown, Dose and Route: Unknown dose, injection given in arm), administration date: 04Mar2021, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "Slight headache", "Had achiness to the injection arm".  The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "Slight headache"; VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "achiness to the injection arm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, vaccination site pain.  Clinical course: The patient had no prior vaccinations within 4 weeks. High cholesterol sort of has high cholesterol. Stated it wasn't really high, she had a stressful job. Had high cholesterol for the last 10 years. The patient had achiness to the injection arm, put ice on it and it was gone within an hour. The same day as each of her Pfizer COVID-19 Vaccines, she took Tylenol three hours after the vaccine administration. She does this with any vaccine she gets. Tylenol: Dose: 500mg just once. Formulation: blue and red 250mg each capsule, Date Administered: Same day as each of her COVID-19 Vaccines. Time of Use: 3 hours after vaccine administration. History and Investigations: Given a gel injection for her right knee after she was negative for COVID-19. It had nothing to do with COVID-19. Had a Cortisone shot to the right knee in Feb2022, before getting COVID-19. Her right knee has been giving her problems.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201240143 Same patient and drug, different event separated in time;
Right lower arm has a 50 cent size swollen red area, started on 4-6-16. On 4-7-16, left deltoid area red "size of a baseball and rock hard."  No fever.
Administrative error - second dose was given 14 days early due to clerical error on form (missing date of first dose). First dose was administered 22APR2021, second dose given 6MAY2021.
transient mild hearing loss; Mild dizziness; vertigo; nausea/nauseated; unable to drive; ringing in my ears; not able to perform daily activities such as a mild workout routine/perform tasks needing focus and movement; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for two doses. This is the first of two reports, for second dose. This case is serious. A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered in Arm Left on 27Jun2021 17:00 (at the age of 50-years-old) (Lot Number: EW0217) as single dose for covid-19 immunisation. Medical history included high blood pressure, heart palpitations, meniere's disease and covid prior vaccination. The patient did not receive other vaccine in four weeks. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); amlodipine besilate (NORVASC); hydrochlorothiazide; ethinylestradiol, etynodiol diacetate (KELNOR).  The patient previously took amoxycillin and had known allergies to amoxicillin. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered in Arm Left on 06Jun2021 17:00 (at the age of 50-years-old) (Lot Number: EW0202) as single dose for covid-19 immunisation and experienced mild dizziness for the first 2 days. The patient experienced mild dizziness for the first 2 days after each vaccine. Late on 2nd day of the 2nd dose, she experienced severe vertigo and nausea which lasted several days. She was unable to drive or perform tasks needing focus and movement. After the first several days, she had experienced long term mild to moderate dizziness/vertigo along with ringing in her ears and transient mild hearing loss. The number of days experiencing this had decreased slightly but she still experienced it almost daily. Some days she felt no dizziness, other days its mild and about 1 - 2 times per week she was very dizzy and nauseated and was not able to perform daily activities such as a mild workout routine. All events onset on 29Jun2021 18:00. The events resulted in Doctor or other healthcare professional office/clinic visit. Treatment received for the events included antihistamine treatment. The patient had no covid tested post vaccination. The outcome of the events was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101065738 same reporter/product/patient, different dose/similar event
Had rash from head to toe on the morning after shots- red macular no urticarias no diffusions no fever. Also had apprx. dime-sized area induration on right thigh no cellulitis and seen in the ER 09/14/2002 and in office 09/17/2002.
Unknown date and time of onset. Sometime in January 2015 when patient was traveling. Muscle weakness in legs, which eventually resolved, and trouble swallowing as residual effects which have not fully resolved.
On a hot day of May 24, 2021, 4:00 PM, patient was doing some work on his vehicle outside ,went inside the house, complaining of being  so dizzy. Sat on the couch, asked for a glass of water.  Unable to drink, move or talk, and was totally blocked out.  After a minute, was able to move, but unstable sitting down.  Complained of feeling to throw up.  Called 911, Paramedics came, patient recovered from the episode. Had ECG, blood pressure was taken, Results were okay. No trace of Heart Attack or Stroke.  Half hour fast, patient was okay.
This case was reported by a other health professional via sales rep and described the occurrence of fever in a 60-year-old male patient who received SHINGRIX for prophylaxis. On 5th July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever and vomiting. On an unknown date, the outcome of the fever and vomiting were recovered/resolved. It was unknown if the reporter considered the fever and vomiting to be related to SHINGRIX. Additional details were reported as follows: This case was reported by the office manager/ vaccine coordinator. The age at vaccination was not reported, however it could be 59 or 60 years. The patient received a dose of SHINGRIX in the office. The patient experienced a temperature of 105 degrees and vomiting. The patient went to emergency room. The symptoms were acute and lasted for 1 to 2 days. The reporter did not agree to follow up.
Breathing problems, cough, chest pain.  Diagnosed with pulmonary embolism and leg clot after 2 months of symptoms
Platelet count of 4, bleeding (nose, urine. stool), petechiae & bruising over body.  Patient given platelet transfusion, high dose dexamethasone and IVIG.  Platelet count rose to 29.  Discharged and follow-up with hematology
STROKE AS A RESULT OF RECEIVING THE J&J VACCINE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received JNJ78436735 (Ad26.COV2.S) (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination at unknown site. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced stroke as a result of receiving the j&j vaccine. The action taken with JNJ78436735 (Ad26.COV2.S) was not applicable. The outcome of stroke as a result of receiving the j&j vaccine was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210353970 - COVID-19 VACCINE AD26.COV2.S - Stroke. This event is considered Unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Swelling around injection site. Red rash in 6? diameter of injection site. Moderate itching. Warmth/fever of injection site. Began 1 week after 1st vaccine. Lasted for about 3-4 days. Applied hydrocortisone cream, thought to take Benadryl but didn?t know if recommended or would interfere with vaccine. (Covid Arm)
about a week after the injection i noted my left upper arm to be red, hot and itchy. In the following days a distinct circular lesion about 2" in diameter developed, then subsided.  It continued to be red and hot.  Relief was achieved after benadryl 25 mg bid x 2 days .  Stopped for a day and then hot red returned on 15th day.
flu like symptoms; low grade fever; body aches; This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms, fever and general body pain. On an unknown date, the outcome of the influenza-like symptoms, fever and general body pain were unknown.   It was unknown if the reporter considered the influenza-like symptoms, fever and general body pain to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. 1 out of 6 people may get flu like symptoms of low grade fever and body aches. This case had been linked to US2020030262, reported by same reporter.
No additional AE reported.; Nurse reports a 17.5 year old male patient was administered an adult dose of VAQTA; This spontaneous report was received from nurse and refers to a 17.5-year-old male patient.   The patient's medical history, concurrent conditions, drugs reactions or allergies and concomitant therapies were not reported.  On 08-APR-2022, the patient was vaccinated with an adult dose of hepatitis a vaccine, inactivated (VAQTA) (lot #T036739 and expiration date: 22-APR-2022)(exact dose, route of administration and anatomical location were not provided) for prophylaxis (Product administered to patient of inappropriate age). No additional adverse event was reported (No adverse event).
noted persistent fatigue, new and more severe bone & joint pain esp. in feet and hands. Muscle soreness in thighs, groin pain.
mom called 24 hrs p/vax administered; states pt cried all day & noc; had trouble sleeping & would not take formula; lt leg very swollen & red; mom reports only sl fever;
Febrile illness (103-104 fever spikes), myalgias, arthralgias, testicular swelling/pain x 3 weeks.
Pt developed rash at injection site and hives on heads and neck. She visited her dermatologist and took an antihistamine. Reaction resolved.
Soon after receiving HBV (#2) on left deltoid, stated she felt faint, hearing was distant, blurred vision and was not feeling too well. With time, color to skin recovered, she was not as clammy, BP increased from 90/54 to 102/60 within 10 minutes, pulse increased from thready to 60's regular.
Shingles outbreak; This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After administration of Shingrix the patient experienced shingles outbreak.
Increasing pain at injection site beginning 4 hours after injection. Pt then developed swelling, nausea, diaphoresis, fever to 102 degrees F, and transient numbness at injection site.
Severe chills, headache, lack of appetite and Temp of 101.9 for 5 days following injection.
woke up and left deltoid dark red, puffy is swollen like a sausage.  Could not lift up arm for four days.  Hot to touch.  Size measured 5-20-09 10 1/2cm (height) by 7cm (width) site still pink and slight warm to touch.  Circle bandaid was used- can still see white circle where bandaid was applied.
Started to have a reaction at the injection site 24 hours after vaccine. Warm red large area to Lt thigh.
Tightness around the arm where she had the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of SKIN TIGHTNESS (Tightness around the arm where she had the vaccination) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced SKIN TIGHTNESS (Tightness around the arm where she had the vaccination). On 01-Mar-2021, SKIN TIGHTNESS (Tightness around the arm where she had the vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: TCR-event resolved
pt states that she woke up with severe cramps in both legs.  she could not walk because of the pain.  she applied heated blankets.  she had extreme fatigue, loss of appetite, nauseated, slight fever, and feeling bad all over.  These symptoms lasted a couple of days.  She still has some hypersensitivity on the right side of her the forehead.  she cant see anything but can feel it.
bloody mucoid stools.  no diarrhea, fever, straining, exam wnl
Sweating, chills, local site pain and swelling, body aches, patient says felt like flu but did not check the temperature, no vomiting.
heart palpitations that lasted hours happened a few times 1 month afte shot.  1 month later hear palpitations lasted all night and I developed insomnia because of that 1 sleepless night.  Left arm pain laster about 6 weeks and currently feel pain at times.
Client called PHN and reported a general "not well" feeling within 24 hours of vaccine. 48 hours after vaccination, left arm pit was swollen with knots under arm, and arm tingled and felt numb. Took Benadryl and Tylenol which helped.
rash on the injection site; tiredness; on and off headache; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (tiredness), HEADACHE (on and off headache) and VACCINATION SITE RASH (rash on the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 100L20A) for COVID-19 vaccination.     The patient's past medical history included Allergy multiple (Not specified).  On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 12-Jan-2021, the patient experienced FATIGUE (tiredness) and HEADACHE (on and off headache). On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (rash on the injection site). On 13-Jan-2021, FATIGUE (tiredness) had resolved. On 16-Jan-2021, HEADACHE (on and off headache) had resolved. At the time of the report, VACCINATION SITE RASH (rash on the injection site) outcome was unknown. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Arm became very sore. So sore it was difficult to sleep or use my arm. I tried to wait to see if it would just get better, but it remained too sore to lift above shoulder level for 2 weeks. Symptoms have improved with regular NSAID use, but the muscles are still sore and the shoulder seems to have sustained an injury of some kind (it has now been a month). I am going to go to the doctor soon to see what is going on.
Right shoulder pain and limited range of motion immediately after a "too high" influenza vaccine injection.  Pain has improved but is still present 7 months later. Diagnosis is Shoulder Injury Related to Vaccine Administration (SIRVA)
Coughing; Tightness in chest; Exhaustion; COVID-19; Lack of drug effect; Lost hearing; Sinus infection / Head congestion; Allergy attack; Sneezing; Blowing her nose al the time; Really bad ear pain; Pain in her teeth; Lost sense of taste; Lost sense of smell; Insomnia; This spontaneous case was reported by a consumer and describes the occurrence of DEAFNESS (Lost hearing) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, the patient experienced DEAFNESS (Lost hearing) (seriousness criterion medically significant), SINUSITIS (Sinus infection / Head congestion), HYPERSENSITIVITY (Allergy attack), SNEEZING (Sneezing), RHINORRHOEA (Blowing her nose al the time), EAR PAIN (Really bad ear pain), TOOTHACHE (Pain in her teeth), AGEUSIA (Lost sense of taste), ANOSMIA (Lost sense of smell) and INSOMNIA (Insomnia). On 27-Aug-2021, the patient experienced COVID-19 (COVID-19) and DRUG INEFFECTIVE (Lack of drug effect). On 29-Aug-2021, the patient experienced COUGH (Coughing), CHEST DISCOMFORT (Tightness in chest) and FATIGUE (Exhaustion). At the time of the report, DEAFNESS (Lost hearing), SINUSITIS (Sinus infection / Head congestion), HYPERSENSITIVITY (Allergy attack), SNEEZING (Sneezing), RHINORRHOEA (Blowing her nose al the time), EAR PAIN (Really bad ear pain), TOOTHACHE (Pain in her teeth), AGEUSIA (Lost sense of taste), ANOSMIA (Lost sense of smell), INSOMNIA (Insomnia), COUGH (Coughing), CHEST DISCOMFORT (Tightness in chest), COVID-19 (COVID-19), DRUG INEFFECTIVE (Lack of drug effect) and FATIGUE (Exhaustion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Aug-2021, SARS-CoV-2 test: positive (Positive) COVID-19 virus test positive.         Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Head to toe macular papular rash. Purplish face coloring, fussiness, fever, runny nose and swollen face.